Enhanced Anastomosis System with Synergistic Technologies

The inventive concept integrates the original partial eversion anastomosis juncture formation and suturing method with advanced technologies such as AI, IoT, blockchain, and nanomaterials to create a more efficient, accurate, and secure anastomosis procedure.

The original patent addressed the challenge of connecting or reconnecting segments of passages in surgical anastomosis. However, the existing method had limitations in terms of accuracy, speed, and data management. The new inventive concept solves these problems by incorporating synergistic technologies that enhance the anastomosis procedure, improve patient outcomes, and provide secure data management.

The enhanced anastomosis system comprises a robotic arm, computer vision system, machine learning algorithms, blockchain-based data storage, nanomaterial-based coating, and IoT-enabled sensor network. The robotic arm assists in everting the distal portions of the donor and receiving passages, while the computer vision system provides real-time monitoring and guidance. Machine learning algorithms analyze data from sensors and cameras to optimize the everting process and improve accuracy. The blockchain-based data storage system securely stores and tracks patient data and surgical outcomes, and the communication module facilitates secure data sharing between healthcare providers. The nanomaterial-based coating enhances biocompatibility and reduces the risk of complications, and the sensor monitors the passages for signs of rejection or infection. The IoT-enabled sensor network monitors the anastomosis procedure in real-time, and the cloud-based analytics platform analyzes data to provide insights for improving surgical outcomes.

The new claims introduce novel combinations of technologies that significantly improve the anastomosis procedure. The integration of AI, IoT, blockchain, and nanomaterials with the original method provides a non-obvious solution that overcomes the limitations of the prior art.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, varying nanomaterial compositions, or alternative blockchain platforms. The system could also be adapted for use in different types of surgical procedures or in non-surgical applications.

The enhanced anastomosis system has significant commercial potential in the medical device industry, particularly in the fields of cardiovascular, neurovascular, and gastrointestinal surgery. The system's ability to improve accuracy, reduce complications, and provide secure data management makes it an attractive solution for healthcare providers and patients alike.